NEWS COMMENTARY

Perfect Day receives FDA approval for its fermentation-derived dairy protein

Published:
April 15, 2020
Services:
Chemicals More...
Topics:
Synthetic Biology | Functional Ingredients  More... | Personalized Nutrition | Algae | Fermentation-Derived Protein | Ingredient Informatics | Plant-Derived Ingredients | AI-Enabled Drug Discovery | Alternative Ingredients | Alternative Proteins
Activities:
Policy
by Harini Venkataraman
Average importance

Perfect Day received "no objection" from the FDA for its dairy protein ingredient beta-lactoglobulin, produced in an engineered strain of Trichoderma reesei. This definitive decision based on the company's self-affirmed GRAS status is a key milestone as Perfect Day looks to ramp up production and get to the market following its recent $140 million Series C funding. As Lux pointed out, the FDA's amendment on voluntary GRAS affirmation will significantly reduce waiting time for regulatory approval, often a key hurdle for commercializing new food ingredients produced using microbial fermentation. Clients should expect to see similar developments on the regulatory front from other startups targeting the fermentation-derived food proteins space.

For the original news article, click here .


Further Reading

Clara Foods launches animal-free pepsin as its first B2B ingredient

News Commentary | March 15, 2021

While Clara Foods' initial focus was on producing animal‑free egg proteins, it has now entered the market with pepsin as its first product. The company uses a yeast‑based expression system to produce this enzyme, with a granted patent in the U.S. Building on its existing partnership, Ingredion will ... Not part of subscription

NutriLeads

Company Snapshot | September 09, 2021

The company was founded by Ruud Albers (CSO) and Erik Dam, who has recently been appointed as CEO. So far, the company has raised about $11.9 million, including $7.7 million from a Series B round in 2020. Among its investors, we emphasize Icos Capital, DSM Venturing, Shift Invest. The company is a ... To read more, click here.

ADM to strengthen its gut health portfolio by acquiring Deerland Probiotics & Enzymes

News Commentary | November 11, 2021

ADM has been keen on growing its gut health offerings, starting with the acquisition of Protexin in 2018. Over the past couple of years, the company has also expanded its existing product categories to accommodate new application areas. While the financial details of Deerland's acquisition are not ... To read more, click here.